8LBA Two year overall survival rate of all advanced melanoma patients treated with ipilimumab in Australia 2013–2014

Publication date: February 2017
Source:European Journal of Cancer, Volume 72, Supplement 1
Author(s): H. Kim, S. Comey




http://ift.tt/2k0xYas